Intrastructural help: improving the HIV-1 envelope antibody response induced by virus-like particle vaccines

被引:0
作者
Temchura, Vladimir [1 ]
Ueberla, Klaus [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Inst Clin & Mol Virol, Schlossgarten 4, D-91054 Erlangen, Germany
关键词
HIV-1 envelope antibody; intrastructural help; T-helper cell; vaccine; T-CELLS; NEUTRALIZING ANTIBODIES; INTERNAL COMPONENTS; DOUBLE-BLIND; EFFICACY; IMMUNIZATION; INFECTION; RISK; ENV; SPECIFICITY;
D O I
10.1097/COH.0000000000000358
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The importance of IgG Fc-effector functions for the efficacy of HIV vaccines is increasingly recognized. Although different types of vaccines were shown to induce antibodies with different Fc-activities, there is no clear strategy how to raise antibody responses with a desired pattern of Fc-effector functions. Given the central role of T-helper cells in regulating the germinal center reaction and the differentiation of B cells in an antigen-specific manner, the review will discuss whether T-helper cells directed against non-HIV envelope (Env) antigens could be harnessed to improve the HIV-Env antibody response. Recent findings Comparing CD4(+) T-cell responses in HIV-infected individuals with and without neutralizing antibody breadth suggests that robust Gag-specific CD4(+) T cells may provide important T-cell help to Env-specific B cells. In a murine model, GagPol-specific T-helper cells were shown to provide intrastructural help for HIVEnv- specific antibody responses after immunization with a virus-like particle vaccine. GagPol-specific Thelper cells imprinted the IgG subtype ratio observed for Gag onto the HIV-Env antibody response and modulated the glycosylation pattern of the HIV Env-specific antibodies. Summary Intrastructural help is a promising strategy to improve overall levels and Fc-effector functions of the HIV-Env antibody response.
引用
收藏
页码:272 / 277
页数:6
相关论文
共 46 条
[1]   Impact of Glycosylation on Effector Functions of Therapeutic IgG [J].
Abes, Riad ;
Teillaud, Jean-Luc .
PHARMACEUTICALS, 2010, 3 (01) :146-157
[2]   Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control [J].
Ackerman, Margaret E. ;
Mikhailova, Anastassia ;
Brown, Eric P. ;
Dowell, Karen G. ;
Walker, Bruce D. ;
Bailey-Kellogg, Chris ;
Suscovich, Todd J. ;
Alter, Galit .
PLOS PATHOGENS, 2016, 12 (01)
[3]   IgG Subclass Profiles in Infected HIV Type 1 Controllers and Chronic Progressors and in Uninfected Recipients of Env Vaccines [J].
Banerjee, Kaustuv ;
Klasse, P. J. ;
Sanders, Rogier W. ;
Pereyra, Florencia ;
Michael, Elizabeth ;
Lu, Min ;
Walker, Bruce D. ;
Moore, John P. .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (04) :445-458
[4]   Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo [J].
Banerjee, Kaustuv ;
Andjelic, Sofija ;
Klasse, Per Johan ;
Kang, Yun ;
Sanders, Rogier W. ;
Michael, Elizabeth ;
Durso, Robert J. ;
Ketas, Thomas J. ;
Olson, William C. ;
Moore, John P. .
VIROLOGY, 2009, 389 (1-2) :108-121
[5]   Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys [J].
Barouch, Dan H. ;
Liu, Jinyan ;
Li, Hualin ;
Maxfield, Lori F. ;
Abbink, Peter ;
Lynch, Diana M. ;
Iampietro, M. Justin ;
SanMiguel, Adam ;
Seaman, Michael S. ;
Ferrari, Guido ;
Forthal, Donald N. ;
Ourmanov, Ilnour ;
Hirsch, Vanessa M. ;
Carville, Angela ;
Mansfield, Keith G. ;
Stablein, Donald ;
Pau, Maria G. ;
Schuitemaker, Hanneke ;
Sadoff, Jerald C. ;
Billings, Erik A. ;
Rao, Mangala ;
Robb, Merlin L. ;
Kim, Jerome H. ;
Marovich, Mary A. ;
Goudsmit, Jaap ;
Michael, Nelson L. .
NATURE, 2012, 482 (7383) :89-U115
[6]   Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C [J].
Binley, James M. ;
Lybarger, Elizabeth A. ;
Crooks, Emma T. ;
Seaman, Michael S. ;
Gray, Elin ;
Davis, Katie L. ;
Decker, Julie M. ;
Wycuff, Diane ;
Harris, Linda ;
Hawkins, Natalie ;
Wood, Blake ;
Nathe, Cory ;
Richman, Douglas ;
Tomaras, Georgia D. ;
Bibollet-Ruche, Frederic ;
Robinson, James E. ;
Morris, Lynn ;
Shaw, George M. ;
Montefiori, David C. ;
Mascola, John R. .
JOURNAL OF VIROLOGY, 2008, 82 (23) :11651-11668
[7]   Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells [J].
Bonsmann, Michael Storcksdieck Genannt ;
Niezold, Thomas ;
Temchura, Vladimir ;
Pissani, Franco ;
Ehrhardt, Katrin ;
Brown, Eric P. ;
Osei-Owusu, Nana Yaw ;
Hannaman, Drew ;
Hengel, Hartmut ;
Ackerman, Margaret E. ;
Streeck, Hendrik ;
Nabi, Ghulam ;
Tenbusch, Matthias ;
Ueberla, Klaus .
JOURNAL OF IMMUNOLOGY, 2015, 195 (10) :4861-4872
[8]  
BROLIDEN PA, 1989, CLIN EXP IMMUNOL, V76, P216
[9]   Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial [J].
Buchbinder, Susan P. ;
Mehrotra, Devon V. ;
Duerr, Ann ;
Fitzgerald, Daniel W. ;
Mogg, Robin ;
Li, David ;
Gilbert, Peter B. ;
Lama, Javier R. ;
Marmor, Michael ;
del Rio, Carlos ;
McElrath, M. Juliana ;
Casimiro, Danilo R. ;
Gottesdiener, Keith M. ;
Chodakewitz, Jeffrey A. ;
Corey, Lawrence ;
Robertson, Michael N. .
LANCET, 2008, 372 (9653) :1881-1893
[10]   Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag [J].
Casimiro, DR ;
Wang, FB ;
Schleif, WA ;
Liang, XP ;
Zhang, ZQ ;
Tobery, TW ;
Davies, ME ;
McDermott, AB ;
O'Connor, DH ;
Fridman, A ;
Bagchi, A ;
Tussey, LG ;
Bett, AJ ;
Finnefrock, AC ;
Fu, TM ;
Tang, AM ;
Wilson, KA ;
Chen, MC ;
Perry, HC ;
Heidecker, GJ ;
Freed, DC ;
Carella, A ;
Punt, KS ;
Sykes, KJ ;
Huang, LY ;
Ausensi, VI ;
Bachinsky, M ;
Sadasivan-Nair, U ;
Watkins, DI ;
Emini, EA ;
Shiver, JW .
JOURNAL OF VIROLOGY, 2005, 79 (24) :15547-15555